Literature DB >> 30112746

Current Options for the Treatment of Pectus Carinatum: When to Brace and When to Operate?

Sherif Emil1,2.   

Abstract

Pectus carinatum has traditionally been described as a rare chest wall anomaly in comparison to pectus excavatum. However, recent data from chest wall anomaly clinics demonstrate that this deformity is probably much more frequent than once believed. In the past, invasive surgical correction by the Ravitch technique was essentially the only option for treatment of pectus carinatum. Major advances over the past two decades have provided additional options, including noninvasive chest wall bracing and minimally invasive surgical correction. This article will discuss current options for the treatment of pectus carinatum, and some of the factors that should be taken into account when choosing the options available. Diagnosis and treatment of the pectus arcuatum variant will also be described. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30112746     DOI: 10.1055/s-0038-1667297

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  3 in total

1.  Amianthoid transformation of costal cartilage matrix in children with pectus excavatum and pectus carinatum.

Authors:  Alexandr Kurkov; Anna Guller; Alexey Fayzullin; Nafisa Fayzullinа; Vladimir Plyakin; Svetlana Kotova; Petr Timashev; Anastasia Frolova; Nikita Kurtak; Vyacheslav Paukov; Anatoly Shekhter
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

2.  Currarino-Silverman syndrome: diagnosis and treatment of rare chest wall deformity, a case series.

Authors:  Andrei I Gritsiuta; Alexander Bracken; Karisa Beebe; Alexei A Pechetov
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

3.  Safety and feasibility of rigid fixation by SternaLock Blu plates during the modified Ravitch procedure: a pilot study.

Authors:  Erik R de Loos; Paul C M Andel; Jean H T Daemen; Jos G Maessen; Karel W E Hulsewé; Yvonne L J Vissers
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.